PFA Pension Forsikringsaktieselskab Invests $9.01 Million in Humana Inc. $HUM

Key Points

• PFA Pension bought a new stake of 34,792 Humana shares valued at approximately $9.01 million during the fourth quarter (13F filing).
• Humana beat recent quarterly expectations with EPS of $10.31 versus $9.97 expected and revenue of $39.65 billion (up 23.5% year-over-year), and has FY2026 guidance around 9.00 EPS with analysts forecasting about 9.06.
• The company announced a quarterly dividend of $0.885 (annualized $3.54, ~1.5% yield) and is highly institutionally owned (about 92.4%); an insider also recently purchased 810 shares.

PFA Pension Forsikringsaktieselskab bought a new stake in Humana Inc. (NYSE:HUM - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 34,792 shares of the insurance provider's stock, valued at approximately $9,013,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. CoreCap Advisors LLC lifted its stake in Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider's stock worth $27,000 after purchasing an additional 37 shares during the last quarter. Rosenberg Matthew Hamilton boosted its holdings in Humana by 136.0% in the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider's stock valued at $30,000 after purchasing an additional 68 shares in the last quarter. Mather Group LLC. purchased a new position in Humana in the third quarter valued at approximately $34,000. Larson Financial Group LLC increased its stake in Humana by 114.1% in the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider's stock valued at $40,000 after purchasing an additional 81 shares during the last quarter. Finally, Fulcrum Asset Management LLP acquired a new stake in Humana during the third quarter worth approximately $42,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Trading Up 2.0%

Shares of Humana stock opened at $238.22 on Tuesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The company has a market capitalization of $28.60 billion, a P/E ratio of 25.48, a PEG ratio of 2.16 and a beta of 0.68. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $315.35. The company's fifty day moving average is $188.41 and its two-hundred day moving average is $226.98.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, beating analysts' consensus estimates of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business had revenue of $39.65 billion during the quarter, compared to analysts' expectations of $39.37 billion. During the same period in the prior year, the company earned $11.58 earnings per share. The business's revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. Analysts forecast that Humana Inc. will post 9.06 earnings per share for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $3.54 annualized dividend and a yield of 1.5%. Humana's dividend payout ratio is currently 37.86%.

Insiders Place Their Bets

In related news, insider Sanjay K. Shetty acquired 810 shares of the firm's stock in a transaction on Monday, February 23rd. The stock was bought at an average cost of $185.21 per share, with a total value of $150,020.10. Following the transaction, the insider owned 11,657 shares of the company's stock, valued at $2,158,992.97. The trade was a 7.47% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.20% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. Zacks Research downgraded shares of Humana from a "hold" rating to a "strong sell" rating in a research report on Tuesday, April 14th. Leerink Partners lifted their price target on shares of Humana from $185.00 to $255.00 and gave the stock a "market perform" rating in a research note on Thursday, April 30th. Morgan Stanley set a $146.00 price target on shares of Humana in a research report on Thursday, February 12th. Wolfe Research decreased their price objective on shares of Humana from $325.00 to $250.00 and set an "outperform" rating for the company in a research note on Monday, April 6th. Finally, Evercore raised their price objective on Humana from $195.00 to $250.00 in a report on Thursday, April 30th. Seven research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat.com, Humana has a consensus rating of "Hold" and an average target price of $247.61.

Humana Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.